BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BOC | BOC cell adhesion associated, oncogene regulated | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
BRAP | BRCA1 associated protein | RAS pathway related proteins
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C11orf1 | Chromosome 11 open reading frame 1 | Predicted secreted proteins
| | | | | Expressed in all |
C14orf159 | Chromosome 14 open reading frame 159 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C17orf70 | Chromosome 17 open reading frame 70 | | | | | | Expressed in all |
C18orf54 | Chromosome 18 open reading frame 54 | Predicted secreted proteins
| | | | | Tissue enhanced |
C19orf47 | Chromosome 19 open reading frame 47 | Predicted secreted proteins
| | | | | Expressed in all |
C19orf80 | Chromosome 19 open reading frame 80 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf198 | Chromosome 1 open reading frame 198 | Predicted secreted proteins
| | | | | Expressed in all |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C4orf48 | Chromosome 4 open reading frame 48 | Predicted secreted proteins
| | | | | Mixed |
C7orf43 | Chromosome 7 open reading frame 43 | Predicted secreted proteins
| | | | | Expressed in all |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CARD8 | Caspase recruitment domain family, member 8 | Predicted membrane proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CCBL1 | Cysteine conjugate-beta lyase, cytoplasmic | Enzymes
| | | | | Expressed in all |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC149 | Coiled-coil domain containing 149 | Predicted secreted proteins
| | | | | Expressed in all |
CCDC19 | Coiled-coil domain containing 19 | | | | | | Group enriched |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
CCNL1 | Cyclin L1 | Predicted secreted proteins
| | | | | Tissue enriched |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CENPO | Centromere protein O | | | | | | Mixed |
CENPV | Centromere protein V | | | | | | Expressed in all |